カテゴリ： MarketLine, アメリカ, 企業調査

Milliken & Company：戦略・SWOT・企業財務分析

◆英語タイトル：Milliken & Company - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015597
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：化学・材料
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Milliken & Company – Strategy, SWOT and Corporate Finance Report
Summary

Milliken & Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Milliken & Company (Milliken or ‘the company’) is a privately-held textile and chemical manufacturing company. It is engaged in manufacturing fabrics for rugs and carpets, as well as other synthetic fabrics. The company has its operations spread across the Americas, Europe and Asia. It is headquartered in Spartanburg, South Carolina and employs over 7,000 people.

Scope

- Detailed information on Milliken & Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Milliken & Company in the form of a SWOT analysis
- An in-depth view of the business model of Milliken & Company including a breakdown and examination of key business segments
- Intelligence on Milliken & Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Milliken & Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Milliken & Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Milliken & Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Milliken & Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Milliken & Company: Company Overview
Milliken & Company: Overview and Key Facts
Milliken & Company: Overview
Milliken & Company: Key Facts
Milliken & Company: Key Employees
Milliken & Company: Key Employee Biographies
Milliken & Company: Major Products and Services
Milliken & Company: Company History
Milliken & Company: Management Statement
Milliken & Company: Locations and Subsidiaries
Milliken & Company: Key Competitors
Milliken & Company: Company Analysis
Milliken & Company: Business Description
Milliken & Company: SWOT Analysis
Milliken & Company: SWOT Overview
Milliken & Company: Strengths
Milliken & Company: Weaknesses
Milliken & Company: Opportunities
Milliken & Company: Threats
Milliken & Company: Corporate Financial Deals Activity
Milliken & Company: Financial Deals Overview
Milliken & Company: Targets and Partners
Milliken & Company: Top Deals 2013 – 2017YTD*
Milliken & Company: Mergers and Acquisitions
Milliken & Company: Recent Developments
Milliken & Company: News and Events Summary
Milliken & Company: Business Expansion
Milliken & Company: Contracts
Milliken & Company: Regulatory and Legal Events
Milliken & Company: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Milliken & Company: Key Facts
Table 2: Milliken & Company: Key Employees
Table 3: Milliken & Company: Locations and Subsidiaries
Table 4: Milliken & Company: Key Competitors
Table 5: Milliken & Company: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Milliken & Company: Targets and Partners
Table 7: Milliken & Company: Top Deals 2013 - 2017YTD*
Table 8: Milliken & Company: M&A Volume and Value Trend (2013 - YTD*2017)
Table 9: Milliken & Company: M&A Activity by Geography (2013 - YTD*2017)
Table 10: Milliken & Company: News and Events Summary
Table 11: Milliken & Company: Business Expansion
Table 12: Milliken & Company: Contracts
Table 13: Milliken & Company: Regulatory and Legal Events
Table 14: Milliken & Company: Strategy and Operations

★海外企業調査レポート[Milliken & Company：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Electricite de France SA (EDF)：電力：M&Aディール及び事業提携情報
    Summary Electricite de France S.A. (EDF) is a state-owned integrated energy company that generates, transmits, distributes and sells electricity; supplies natural gas; and offers energy services such as district heating, thermal energy services and other services. The group generates electricity fro …
  • Tempur Sealy International, Inc.：企業の戦略・SWOT・財務情報
    Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Hals-Development：企業の戦略・SWOT・財務情報
    Hals-Development - Strategy, SWOT and Corporate Finance Report Summary Hals-Development - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • HanAll Biopharma Co Ltd (009420)：企業の財務・戦略的SWOT分析
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a developer of generic and specialty drugs for treatment of diseases related to digestive, endocrine, musculoskeletal and urinary system. The company’s pipeline products include HL036, a drug being developed for trea …
  • Japan Vilene Company, Ltd.：戦略・SWOT・企業財務分析
    Japan Vilene Company, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Japan Vilene Company, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cambrex Corp (CBM)：企業の財務・戦略的SWOT分析
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • Les Laboratoires Servier：企業の戦略・SWOT・財務情報
    Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report Summary Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Intercept Pharmaceuticals Inc (ICPT)：企業の財務・戦略的SWOT分析
    Intercept Pharmaceuticals Inc (ICPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Saizeriya Co., Ltd.：企業の戦略・SWOT・財務情報
    Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Saizeriya Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Groupama S.A.：企業の戦略・SWOT・財務情報
    Groupama S.A. - Strategy, SWOT and Corporate Finance Report Summary Groupama S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Humana Inc.：企業のM&A・事業提携・投資動向
    Humana Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Humana Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • National Grid USA Service Co Inc：企業の戦略的SWOT分析
    National Grid USA Service Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Reply S.p.A. (REY)：企業の財務・戦略的SWOT分析
    Reply S.p.A. (REY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Banco Hipotecario SA (BHIP3)：企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Dhamma Energy：電力：M&Aディール及び事業提携情報
    Summary Dhamma Energy (Dhamma) is an energy services company that develops, operates and invests in solar photovoltaic installations. The company's services cover the technical and financial studies, development and acquisition, construction and commissioning, and operation and maintenance stages of …
  • Catholic Health Initiatives：製薬・医療：M&Aディール及び事業提携情報
    Summary Catholic Health Initiatives (CHI) is a health system comprising of non-profit and for profit corporations and other organizations including Catholic health care systems. It serves people through operations and facilities that span the continuum of care, comprising acute care hospitals; long- …
  • Asahi Kasei Corp (3407)：製薬・医療：M&Aディール及び事業提携情報
    Summary Asahi Kasei Corp (Asahi Kasei), manufactures, and markets chemical products. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation panels, foundation systems, methyl methacrylate, adipic acid, polyethylene, polystyrene, functiona …
  • Beadell Resources Ltd：企業の戦略・SWOT・財務情報
    Beadell Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Beadell Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ThyssenKrupp AG：企業のM&A・事業提携・投資動向
    ThyssenKrupp AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThyssenKrupp AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Umecrine Cognition AB-製薬・医療分野：企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆